---
figid: PMC4842340__nihms733277f2
figlink: /pmc/articles/PMC4842340/figure/F2/
number: Figure 2
caption: Schematic representation of involvement of the prohibitin (PHB/PHB1) in granulosa
  cell (GCs) survival and differentiation functions. The schematic diagram showing
  the supportive role played by PHB/pPHB through Ras-Raf-MEK-ERK pathway in FSH induced
  differentiation and survival role in GCs. FSH induces up-regulation of PHB/pPHB,
  OPA1 (optic atrophy 1 (autosomal dominant)), steroidogenic acute regulatory protein
  (StAR), p450 cholesterol side-chain cleavage enzyme (p450scc), hydroxysteroid dehydrogenase-3β
  (HSD-3β), and aromatase (cyp19/cyp11a) leading to stimulation of synthesis and secretions
  of estrogen (E2) and progesterone (P4). Moreover, PHB acting through phospho-PHB
  (pPHB) mediate activation of pERK expression resulting in enhancement of the Bcl/Bcl-xL
  pathway and inhibition of Bax-Bak pathway. These events directly inhibit the release
  of cytochrome c from the inter-mitochondrial space resulting in inhibition of the
  downstream activation of cleaved caspase 3. ER-Endoplasmic reticulum, FSH-Follicle
  stimulating hormone, P-phosphate, Bcl2-B-cell CLL/lymphoma 2, Bclxl-B-cell lymphoma-extra
  large, Bax-BCL2-Associated X Protein, Bak-Bcl-2 homologous antagonist/killer, Ras-Rat
  sarcoma protein, Raf-Rapidly Accelerated Fibrosarcoma, MEK-Mitogen-activated protein
  kinase, ERK-Extracellular signal regulated kinase.
pmcid: PMC4842340
papertitle: Prohibitin (PHB) roles in granulosa cell physiology.
reftext: Indrajit Chowdhury, et al. Cell Tissue Res. ;363(1):19-29.
pmc_ranked_result_index: '37142'
pathway_score: 0.9163737
filename: nihms733277f2.jpg
figtitle: Involvement of the prohibitin (PHB/PHB1) in granulosa cell (GCs) survival
  and differentiation functions
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4842340__nihms733277f2.html
  '@type': Dataset
  description: Schematic representation of involvement of the prohibitin (PHB/PHB1)
    in granulosa cell (GCs) survival and differentiation functions. The schematic
    diagram showing the supportive role played by PHB/pPHB through Ras-Raf-MEK-ERK
    pathway in FSH induced differentiation and survival role in GCs. FSH induces up-regulation
    of PHB/pPHB, OPA1 (optic atrophy 1 (autosomal dominant)), steroidogenic acute
    regulatory protein (StAR), p450 cholesterol side-chain cleavage enzyme (p450scc),
    hydroxysteroid dehydrogenase-3β (HSD-3β), and aromatase (cyp19/cyp11a) leading
    to stimulation of synthesis and secretions of estrogen (E2) and progesterone (P4).
    Moreover, PHB acting through phospho-PHB (pPHB) mediate activation of pERK expression
    resulting in enhancement of the Bcl/Bcl-xL pathway and inhibition of Bax-Bak pathway.
    These events directly inhibit the release of cytochrome c from the inter-mitochondrial
    space resulting in inhibition of the downstream activation of cleaved caspase
    3. ER-Endoplasmic reticulum, FSH-Follicle stimulating hormone, P-phosphate, Bcl2-B-cell
    CLL/lymphoma 2, Bclxl-B-cell lymphoma-extra large, Bax-BCL2-Associated X Protein,
    Bak-Bcl-2 homologous antagonist/killer, Ras-Rat sarcoma protein, Raf-Rapidly Accelerated
    Fibrosarcoma, MEK-Mitogen-activated protein kinase, ERK-Extracellular signal regulated
    kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - CGA
  - FSHB
  - CYP19A1
  - KRAS
  - NRAS
  - STAR
  - OPA1
  - MAP2K2
  - ARAF
  - RAF1
  - BRAF
  - BAK1
  - MAPK1
  - MAPK3
  - BAX
  - HRAS
  - CYP11A1
  - PHB
  - BCL2
  - BCL2L1
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FSH
  symbol: FSH
  source: bioentities_symbol
  hgnc_symbol: CGA
  entrez: '1081'
- word: FSH
  symbol: FSH
  source: bioentities_symbol
  hgnc_symbol: FSHB
  entrez: '2488'
- word: Aromatase
  symbol: aromatase
  source: hgnc_alias_symbol
  hgnc_symbol: CYP19A1
  entrez: '1588'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: STAR
  symbol: STAR
  source: hgnc_symbol
  hgnc_symbol: STAR
  entrez: '6770'
- word: OPA1
  symbol: OPA1
  source: hgnc_symbol
  hgnc_symbol: OPA1
  entrez: '4976'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Bak
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: P450scc
  symbol: P450SCC
  source: hgnc_alias_symbol
  hgnc_symbol: CYP11A1
  entrez: '1583'
- word: →→(PHB
  symbol: PHB
  source: hgnc_symbol
  hgnc_symbol: PHB
  entrez: '5245'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Bclxl
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
